Home › Funds › DODGE & COX › REGN

DODGE & COX position in REGN

REGENERON PHARMACEUTICALS · Health Care

DODGE & COX reported holding 4,774,489 shares of REGN (REGENERON PHARMACEUTICALS) in its Q3 2026 13F filing — a position valued at US$3.62B, representing 1.94% of its reported portfolio and ranking #14 among its reported holdings. DODGE & COX has disclosed REGN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)4.77M sh
Reported value held$3.62B
Portfolio Weight1.94%
First reportedQ3 2023
Last changeReduce
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How DODGE & COX's REGN position evolved

DODGE & COX first disclosed a stake in REGN in Q3 2023 at 2,372,998 shares (US$1.95B). The position peaked in Q3 2026 at 4,774,489 shares, worth US$3.62B. Across 13 filings, DODGE & COX increased the stake 4 time(s), trimmed it 3 time(s) and left it unchanged 5 time(s). The most recent filing (Q3 2026) shows 4,774,489 shares valued at US$3.62B — a reduction of -96,648 shares quarter over quarter.. Notable position changes include a 65% increase in Q2 2025 (shares rose 8% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 2.37M $1.95B New
Q4 2023 2.37M $2.08B Hold
Q1 2024 2.36M $2.27B Hold
Q2 2024 2.32M $2.43B Reduce
Q3 2024 2.31M $2.43B Hold
Q4 2024 2.32M $1.65B Hold
Q1 2025 2.32M $1.47B Hold
Q2 2025 3.83M $2.01B Add
Q3 2025 4.55M $2.56B Add
Q4 2025 4.60M $3.55B Add
Q1 2026 4.46M $3.44B Reduce
Q2 2026 4.87M $3.04B Add
Q3 2026 4.77M $3.62B Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About REGN and 13F data

REGN (REGENERON PHARMACEUTICALS) is a Health Care company. 26 other funds we track also report a position in REGN — the largest reported positions include Dodge & Cox (US$3.04B), Franklin Resources (US$2.75B), Nuveen, LLC (US$1.48B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding REGN

All REGN fund holders →

FAQ

How long has DODGE & COX held REGN?

DODGE & COX has disclosed REGN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is DODGE & COX's current position in REGN?

As of Q3 2026, DODGE & COX holds 4.77M shares of REGN (REGENERON PHARMACEUTICALS), valued at $3.62B, representing 1.94% of its reported portfolio and ranking #14.

Has DODGE & COX been buying or selling REGN?

In the latest 13F filing (Q3 2026), DODGE & COX reduced its position in REGN. The position peaked in Q3 2026 at 4.77M shares.

Which other funds hold REGN?

Other major institutional holders of REGN include Dodge & Cox, Franklin Resources, Nuveen, LLC, among 26 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.